| Use of natural AhR ligands as potential therapeutic modalities against inflammatory disorders PB Busbee, M Rouse, M Nagarkatti, PS Nagarkatti Nutrition reviews 71 (6), 353-369, 2013 | 210 | 2013 |
| Resveratrol modulates the gut microbiota to prevent murine colitis development through induction of Tregs and suppression of Th17 cells HR Alrafas, PB Busbee, M Nagarkatti, PS Nagarkatti Journal of leukocyte biology 106 (2), 467-480, 2019 | 159 | 2019 |
| Combination of cannabinoids, delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD), mitigates experimental autoimmune encephalomyelitis (EAE) by altering the gut microbiome ZZ Al-Ghezi, PB Busbee, H Alghetaa, PS Nagarkatti, M Nagarkatti Brain, behavior, and immunity 82, 25-35, 2019 | 145 | 2019 |
| Indole-3-carbinol prevents colitis and associated microbial dysbiosis in an IL-22–dependent manner PB Busbee, L Menzel, HR Alrafas, N Dopkins, W Becker, K Miranda, ... JCI insight 5 (1), 2020 | 123 | 2020 |
| AhR activation leads to massive mobilization of myeloid-derived suppressor cells with immunosuppressive activity through regulation of CXCR2 and microRNA miR-150-5p and miR-543 … WH Neamah, NP Singh, H Alghetaa, OA Abdulla, S Chatterjee, ... The Journal of Immunology 203 (7), 1830-1844, 2019 | 85 | 2019 |
| Resveratrol protects mice against SEB‐induced acute lung injury and mortality by miR‐193a modulation that targets TGF‐β signalling H Alghetaa, A Mohammed, M Sultan, P Busbee, A Murphy, S Chatterjee, ... Journal of cellular and molecular medicine 22 (5), 2644-2655, 2018 | 77 | 2018 |
| Alterations in the gut microbiome and suppression of histone deacetylases by resveratrol are associated with attenuation of colonic inflammation and protection against … HR Alrafas, PB Busbee, KN Chitrala, M Nagarkatti, P Nagarkatti Journal of clinical medicine 9 (6), 1796, 2020 | 69 | 2020 |
| Natural indoles, indole-3-carbinol (I3C) and 3, 3’-diindolylmethane (DIM), attenuate staphylococcal enterotoxin B-mediated liver injury by downregulating miR-31 expression and … PB Busbee, M Nagarkatti, PS Nagarkatti PloS one 10 (2), e0118506, 2015 | 69 | 2015 |
| Natural indoles, indole-3-carbinol and 3, 3′-diindolymethane, inhibit T cell activation by staphylococcal enterotoxin B through epigenetic regulation involving HDAC expression PB Busbee, M Nagarkatti, PS Nagarkatti Toxicology and applied pharmacology 274 (1), 7-16, 2014 | 69 | 2014 |
| Resveratrol downregulates miR‐31 to promote T regulatory cells during prevention of TNBS‐induced colitis HR Alrafas, PB Busbee, M Nagarkatti, PS Nagarkatti Molecular nutrition & food research 64 (1), 1900633, 2020 | 59 | 2020 |
| CD44 deletion leading to attenuation of experimental autoimmune encephalomyelitis results from alterations in gut microbiome in mice KN Chitrala, H Guan, NP Singh, B Busbee, A Gandy, ... European journal of immunology 47 (7), 1188-1199, 2017 | 57 | 2017 |
| Alternative medicines as emerging therapies for inflammatory bowel diseases UP Singh, NP Singh, B Busbee, H Guan, B Singh, RL Price, DD Taub, ... International reviews of immunology 31 (1), 66-84, 2012 | 54 | 2012 |
| AhR activation by TCDD (2, 3, 7, 8-Tetrachlorodibenzo-p-dioxin) attenuates pertussis toxin-induced inflammatory responses by differential regulation of tregs and Th17 cells … ZZ Al-Ghezi, N Singh, P Mehrpouya-Bahrami, PB Busbee, M Nagarkatti, ... Frontiers in microbiology 10, 2349, 2019 | 45 | 2019 |
| Environmental microcystin targets the microbiome and increases the risk of intestinal inflammatory pathology via NOX2 in underlying murine model of Nonalcoholic Fatty Liver Disease S Sarkar, D Kimono, M Albadrani, RK Seth, P Busbee, H Alghetaa, ... Scientific reports 9 (1), 8742, 2019 | 44 | 2019 |
| Leptin antagonist ameliorates chronic colitis in IL-10−/− mice UP Singh, NP Singh, H Guan, B Busbee, RL Price, DD Taub, MK Mishra, ... Immunobiology 218 (12), 1439-1451, 2013 | 43 | 2013 |
| AhR activation leads to alterations in the gut microbiome with consequent effect on induction of myeloid derived suppressor cells in a CXCR2-dependent manner WH Neamah, PB Busbee, H Alghetaa, OA Abdulla, M Nagarkatti, ... International journal of molecular sciences 21 (24), 9613, 2020 | 40 | 2020 |
| The ability of AhR ligands to attenuate delayed type hypersensitivity reaction is associated with alterations in the gut microbiota OA Abdulla, W Neamah, M Sultan, HK Alghetaa, N Singh, PB Busbee, ... Frontiers in Immunology 12, 684727, 2021 | 37 | 2021 |
| The emerging role of leptin antagonist as potential therapeutic option for inflammatory bowel disease UP Singh, NP Singh, H Guan, B Busbee, RL Price, DD Taub, MK Mishra, ... International reviews of immunology 33 (1), 23-33, 2014 | 37 | 2014 |
| Increased H3K4me3 methylation and decreased miR-7113-5p expression lead to enhanced Wnt/β-catenin signaling in immune cells from PTSD patients leading to inflammatory phenotype M Bam, X Yang, BP Busbee, AE Aiello, M Uddin, JP Ginsberg, S Galea, ... Molecular Medicine 26, 1-15, 2020 | 32 | 2020 |
| Endocannabinoid anandamide attenuates acute respiratory distress syndrome through modulation of microbiome in the gut-lung axis M Sultan, K Wilson, OA Abdulla, PB Busbee, A Hall, T Carter, N Singh, ... Cells 10 (12), 3305, 2021 | 25 | 2021 |
